16 hours Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing Zacks

   X     

4 days Amgen: Likely To Be Rangebound (Rating Downgrade) Seeking Alpha

   X     

4 days Amgen’s Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer Zacks

   X     

7 days Amgen (AMGN) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

1 week Amgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X     

1 week Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term Zacks

   X     

2 weeks Amgen Inc. (AMGN) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript) Seeking Alpha

   X     

2 weeks Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

   X     

3 weeks Top Analyst Reports for Microsoft, Exxon Mobil & Amgen Zacks

   X     

3 weeks Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

3 weeks Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade) Seeking Alpha

   X     

3 weeks Amgen: Growth Potential Met By High Debt Levels Seeking Alpha

   X     

3 weeks Amgen: Blockbusters, Emerging Therapies, And Investment Potential Seeking Alpha

   X     

3 weeks Amgen: Strong Fundamentals But Expensive Valuation Justifies A Hold Seeking Alpha

   X     

3 weeks Amgen (AMGN) Advances While Market Declines: Some Information for Investors Zacks

   X     

4 weeks Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

1 month Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks

   X     

1 month Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks

   X     

1 month Amgen stock gains on Novo Nordisk’s weightloss drug blunder FXStreet

   X     

1 month Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. Investor's Business Daily

   X     

1 month Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks

   X     

1 month Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen Investor's Business Daily

   X     

1 month Why Amgen (AMGN) is a Top Growth Stock for the Long-Term Zacks

   X     

1 month Amgen (AMGN) Stock Sinks As Market Gains: Here’s Why Zacks

   X     

1 month Here’s Why Amgen (AMGN) is a Strong Value Stock Zacks

   X     

2 months Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock Zacks

   X     

2 months The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

   X     

2 months Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha

   X     

2 months The Zacks Analyst Blog Highlights Amgen, Eaton, Sony, iMage and Enzo Biochem Zacks

   X     

2 months Top Stock Reports for Amgen, Eaton & Enzo Biochem Zacks

   X     

2 months Amgen Inc. (AMGN) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Amgen Stock Falls 12% in a Month: Should You Buy the Dip? Zacks

   X     

2 months Eli Lilly and Novo Nordisk’s Obesity Moat Just Got Stronger The Wall Street Journal

   X     

2 months Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 months Is Amgen Stock Still a Buy After an Unexpected Reveal of Data? Yahoo Finance

   X     

2 months AMGN Stock Down Despite Strong Data From Obesity Drug Study Zacks

   X     

2 months Amgen’s Phase 2 Results Were Not Bad, Don’t Let Mr. Market Fool You Seeking Alpha

   X     

2 months Amgen: Checks All The Wrong Boxes Seeking Alpha

   X     

2 months Final Trade: JWN, IWM, GCO, AMGN YouTube

   X     

2 months Wait for longer-term data with Amgen’s GLP-1, says Piper Sandler’s Christopher Raymond YouTube

   X     

2 months Amgen stock sinks as weightloss drug fails to impress FXStreet

   X     

2 months Amgen: MariTide Underwhelms, But There Are Ways To Win Seeking Alpha

   X     

2 months Chart of the Day: Amgen YouTube

   X     

2 months Cramer’s Stop Trading: Amgen YouTube

   X     

2 months Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know. Yahoo Finance

   X     

2 months Amgen Dives 5% Despite ‘Truly Remarkable’ Results For Obesity Treatment Investor's Business Daily

   X     

2 months Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know. Yahoo Finance

   X     

2 months Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau YouTube

   X     

2 months These Stocks Are Moving the Most Today: GM, Ford, Amgen, Eli Lilly, Super Micro, Best Buy, Analog Devices, Kohl’s, Semtech, and More Yahoo Finance

   X     

2 months Why Amgen (AMGN) is a Top Value Stock for the Long-Term Zacks

   X     

2 months Amgen Sells Off: Keep Calm And Buy The Dip Seeking Alpha

   X     

2 months Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It Zacks

   X     

2 months Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare FXStreet

   X     

2 months Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate Zacks

   X     

2 months Amgen Inc. (AMGN) UBS Global Healthcare Conference (Transcript) Seeking Alpha

   X     

2 months Trade Tracker: Joe Terranova sells Amgen and buys XBI YouTube

   X     

2 months Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? Investor's Business Daily

   X     

2 months Amgen dismisses bone density concerns related to its new weight-loss drug Investing.com

   X     

2 months Amgen sinks as Cantor flags issues with obesity drug YouTube

   X     

2 months Amgen stock falls as analysts mull over weight loss drug’s bone density data CNBC

   X     

2 months Amgen Drops 7% After A ‘Big Unknown Risk’ Rattles Its Monthly Obesity Shot Investor's Business Daily

   X     

3 months Big Pharma’s Obesity Bonanza Faces New Tests The Wall Street Journal

   X     

3 months Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market Seeking Alpha

   X     

3 months Analyst Report: AMGEN Inc. Yahoo Finance

   X     

3 months Market Digest: AAPL, AMGN, AMP, BBY, CTSH, EPD, MCO, UNP, MA, VRSK, PPC, GEHC Yahoo Finance

   X     

3 months Amgen Inc. (AMGN) Q3 2024 Earnings Call Transcript Seeking Alpha

   X     

3 months Amgen Inc. 2024 Q3 – Results – Earnings Call Presentation Seeking Alpha

   X     

3 months Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFO Investor's Business Daily

   X     

3 months Amgen beats Q3 earnings estimates, raises full-year guidance Investing.com

   X     

3 months Pfizer Unveils Its Next Black Box In Obesity. It’s Taking On Amgen. Investor's Business Daily

   X     

3 months First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN) MarketBeat

   X     

3 months Zacks Research Forecasts Amgen’s Q1 Earnings (NASDAQ:AMGN) MarketBeat

   X     

3 months Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN) MarketBeat

   X     

3 months Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List Seeking Alpha

   X     

3 months Amgen Gears Up to Report Q3 Earnings: Here’s What to Expect Zacks

   X     

3 months Allspring Global Investments Holdings LLC Sells 11,091 Shares of Amgen Inc. (NASDAQ:AMGN) MarketBeat

   X     

3 months Amgen (NASDAQ:AMGN) Stock Rating Reaffirmed by Cantor Fitzgerald MarketBeat

   X     

3 months Amgen Inc. (NASDAQ:AMGN) Shares Sold by Raleigh Capital Management Inc. MarketBeat

   X     

3 months Why Amgen (AMGN) Dipped More Than Broader Market Today Zacks

   X     

3 months Amgen (NASDAQ:AMGN) Price Target Raised to $383.00 MarketBeat

   X     

3 months Penn Davis Mcfarland Inc. Raises Stake in Amgen Inc. (NASDAQ:AMGN) MarketBeat

   X     

3 months Creative Planning Has $63.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) MarketBeat

   X     

3 months Raymond James & Associates Sells 71,201 Shares of Amgen Inc. (NASDAQ:AMGN) MarketBeat

   X